SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-013781
Filing Date
2023-04-27
Accepted
2023-04-27 08:30:16
Documents
14
Period of Report
2023-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46676
2 ex99-1.htm EX-99.1 13754
3 ex99-1_01.jpg GRAPHIC 5773
  Complete submission text file 0001493152-23-013781.txt   253938

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnxt-20230426.xsd EX-101.SCH 3227
5 XBRL LABEL FILE rnxt-20230426_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE rnxt-20230426_pre.xml EX-101.PRE 22789
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3880
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 23852096
SIC: 2834 Pharmaceutical Preparations